Select Publications
Journal articles
2012, 'Challenges in blood pressure measurement in patients treated with maintenance hemodialysis', American Journal of Kidney Diseases, 60, pp. 463 - 472, http://dx.doi.org/10.1053/j.ajkd.2012.04.026
,2012, 'Recent peritonitis associates with mortality among patients treated with peritoneal dialysis', Journal of the American Society of Nephrology, 23, pp. 1398 - 1405, http://dx.doi.org/10.1681/ASN.2011121135
,2012, 'Repeated peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 59, pp. 84 - 91, http://dx.doi.org/10.1053/j.ajkd.2011.06.018
,2012, 'Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27, pp. 2028 - 2036, http://dx.doi.org/10.1093/ndt/gfr582
,2012, 'Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function', Nephrology Dialysis Transplantation, 27, pp. 381 - 387, http://dx.doi.org/10.1093/ndt/gfr274
,2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966
,2012, 'IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS', Kidney Research and Clinical Practice, 31, pp. A87 - A87, http://dx.doi.org/10.1016/j.krcp.2012.04.606
,2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x
,2011, 'Effect of dialysis modality on survival of hepatitis C-infected ESRF patients', Clinical Journal of the American Society of Nephrology, 6, pp. 2657 - 2661, http://dx.doi.org/10.2215/CJN.02200311
,2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041
,2011, 'Relapsing and recurrent peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 58, pp. 429 - 436, http://dx.doi.org/10.1053/j.ajkd.2011.03.022
,2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186
,2011, 'Frequent versus Standard Hemodialysis', NEW ENGLAND JOURNAL OF MEDICINE, 364, pp. 975 - 976, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288170300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Frequent versus standard hemodialysis.', N Engl J Med, 364, pp. 975, http://dx.doi.org/10.1056/NEJMc1100105
,2011, 'Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?', Nephrology, 16, pp. 144 - 153, http://dx.doi.org/10.1111/j.1440-1797.2010.01407.x
,2010, 'beta-RECEPTOR ANTAGONISTS IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS', NEPHROLOGY, 15, pp. 71 - 71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'INTERVENTIONS FOR ERYTHROPOIETIN-RESISTANT ANAEMIA IN DIALYSIS PATIENTS: A SYSTEMATIC REVIEW', NEPHROLOGY, 15, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'RELAPSING AND RECURRENT PERITONEAL DIALYSIS - ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, 15, pp. 57 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'REPEAT PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS: INCIDENCE, CAUSES, PREDICTORS AND OUTCOMES', NEPHROLOGY, 15, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis', Nephrology Dialysis Transplantation, 25, pp. 1973 - 1979, http://dx.doi.org/10.1093/ndt/gfp780
,2009, 'Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients', NDT Plus, 2, pp. 508, http://dx.doi.org/10.1093/ndtplus/sfp095
,2009, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD007554
,2008, 'Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics', Clinical Journal of the American Society of Nephrology, 3, pp. 1711 - 1717, http://dx.doi.org/10.2215/CJN.00190108
,2008, 'Phosphate balance on peritoneal dialysis', PERITONEAL DIALYSIS INTERNATIONAL, 28, pp. S26 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000257889700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Automated and continuous ambulatory peritoneal dialysis have similar outcomes', Kidney International, 73, pp. 480 - 488, http://dx.doi.org/10.1038/sj.ki.5002705
,2008, 'Treatment for peritoneal dialysis-associated peritonitis', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, http://dx.doi.org/10.1002/14651858.CD005284.pub2
,2007, 'Does Sevelamer reduce mortality by slowing of progression of coronary calcification? [9]', Kidney International, 71, pp. 1328 - 1329, http://dx.doi.org/10.1038/sj.ki.5002316
,2006, 'Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis', Journal of Association of Physicians of India, 54, pp. 923 - 926
,2006, 'Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations', Nephrology Dialysis Transplantation, 21, pp. 776 - 783, http://dx.doi.org/10.1093/ndt/gfi248
,2005, 'Food for thought.', Annals of internal medicine, 143, pp. 149, http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00017
,2004, 'Severe muscle weakness due to hyperkalemia', Journal of Association of Physicians of India, 52, pp. 505 - 506
,2004, 'Acute renal tubular injury with acute hepatitis a infection: Is it just a coincidence?', Nephrology, 9, pp. 44 - 46, http://dx.doi.org/10.1111/j.1440-1797.2003.00224.x
,2003, 'Cytomegalovirus nasal polyp after renal transplant', Journal of Association of Physicians of India, 51, pp. 614 - 615
,Conference Papers
2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101164&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, AUSTRIA, Vienna, pp. 413 - 413, presented at 53rd ERA-EDTA Congress, AUSTRIA, Vienna, 21 May 2016 - 24 May 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376653801474&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Abstracts
2024, 'A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial', in Journal of Vascular Access, Vol. 25, pp. 193 - 202, http://dx.doi.org/10.1177/11297298221099134
,2022, 'PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER DOES NOT PREDICT THE SEVERITY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)', in NEPHROLOGY, WILEY, Vol. 27, pp. 47 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease', in Journal of Renal Nutrition, Vol. 32, pp. 58 - 67, http://dx.doi.org/10.1053/j.jrn.2021.07.004
,2021, 'EFFECTS OF PHOSPHATE-LOWERING THERAPY IN NON-DIALYSIS CHRONIC KIDNEY DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSES', in NEPHROLOGY, WILEY, Vol. 26, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000689277100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'GLOMERULAR DISEASE REGISTRY AND BIOBANK (GRIT)', in NEPHROLOGY, WILEY, Vol. 25, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'VARIABILITY IN EGFR AND THE RISK OF MAJOR CLINICAL OUTCOMES IN DIABETES: RESULTS FROM ADVANCE', in NEPHROLOGY, WILEY, Vol. 25, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme', in DIABETOLOGIA, SPRINGER, SPAIN, Barcelona, Vol. 62, pp. S340 - S341, presented at 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Barcelona, 16 September 2019 - 20 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303803039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'IMPROVING CARDIOVASCULAR OUTCOMES THROUGH PHOSPHATE LOWERING IN CKD? BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE 'IMPACT OF PHOSPHATE REDUCTION ON VASCULAR END-POINTS IN CHRONIC KIDNEY DISEASE' (IMPROVE-CKD) STUDY', in NEPHROLOGY, WILEY, Vol. 23, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443138700129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, DENMARK, Copenhagen, Vol. 33, presented at 55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), DENMARK, Copenhagen, 24 May 2018 - 27 May 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000433059800530&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY, IL, Chicago, Vol. 17, pp. 795 - 796, presented at American Transplant Congress, IL, Chicago, 29 April 2017 - 03 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404515704556&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,